Return to content in this issue

 

COVID-19 Publications in Allergy Journals, 2020-2021: A Bibliometric Analysis

D'Amelio CM1,2,3, Gastaminza G1,2,3, Aquerreta I4, Cacho-Asenjo E3,4, Martinez-Simon A3,5, Núñez-Córdoba JM6,7

1Department of Allergy and Clinical Immnunology, Clínica Universidad de Navarra, Pamplona, Spain.
2Spanish Research Network on Asthma, Adverse Drug Reactions, and Allergy (ARADyAL, Red Nacional de Asma, Reacciones Adversas a Fármacos y Alergia) of the Carlos III Health Institute of Madrid, Madrid, Spain.
3IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
4Pharmacy Service, Clínica Universidad de Navarra, Pamplona, Spain.
5Department of Anaesthesia and Critical Care, Clínica Universidad de Navarra, Pamplona, Spain.
6Research Support Service, Central Clinical Trials Unit, Clínica Universidad de Navarra, Pamplona, Spain.
7Institute of Data Science and Artificial Intelligence, University of Navarra, Pamplona, Spain.

J Investig Allergol Clin Immunol 2023; Vol. 33(2)
doi: 10.18176/jiaci.0821

Key words: Allergy, Bibliometrics, COVID-19, Journal impact factor, SARS-CoV-2